Nyitólap /

2026-ban megjelent publikációink

  1. Bartha, Á., Győrffy, B., 2026. TNMplot: An enhanced platform for pharmacological target identification through cross-stage and pan-cancer gene expression analysis. J. Pharmacol. https://doi.org/10.1111/bph.70390
  2. Fekete, J.T., Komócsi, A., Győrffy, B., 2026. NetMetaEasy: enabling rapid and user-friendly network meta-analysis (NMA) for comparative effectiveness research. J. Pharmacol. https://doi.org/10.1111/bph.70391
  3. Győrffy, B., Weltz, B., Szabó, I., 2026. A global interdisciplinary platform for academic age-normalized researcher evaluation. https://doi.org/10.1007/s11192-026-05608-y
  4. Lózsa, R., Szikriszt, B., Németh, E., Szeltner, Z., Martinek, R., Póti, Á., Feik, T., Kollarics, S., Márkus, B.G., Kanu, N., Sztupinszki, Z., Simon, F., Shibata, T., Swanton, C., Szallasi, Z., Richardson, A.L., Szüts, D., 2026. Long-term exposure to the ethanol-derived metabolite acetaldehyde elevates structural genomic alterations but not base substitutions. Biol. 9, 243. https://doi.org/10.1038/s42003-026-09521-1
  5. Meler, A., Gusi-Vives, M., de Barrios, O., Azagra, A., Collazo, O., Melchor, J., Del Monte-Monge, A., Győrffy, B., Verdu-Bou, M., Navarro, J.-T., Martín-Subero, J.I., Roué, G., Ramiro, A.R., Roa, S., Parra, M., 2026. HDAC7 is a key factor for the germinal center reaction and its underexpression is associated with DLBCL prognosis. J. Immunol. 215, vkag015. https://doi.org/10.1093/jimmun/vkag015
  6. Menyhart, O., Müller, D., Győrffy, B., DNA methylation-mediated extracellular matrix gene silencing in colorectal cancer. Semin. Oncol. 53, 152469. https://doi.org/10.1016/j.seminoncol.2026.152469
  7. Nugnes, M.V., Bouhraoua, K.E.A., Zoubiri, M., Pancsa, R., Fichó, E., DisProt Consortium, Tompa, P., Piovesan, D., Tosatto, S.C.E., Aspromonte, M.C., 2026. DisProt in 2026: enhancing intrinsically disordered proteins accessibility, deposition, and annotation. Nucleic Acids Res. 54, D383–D392. https://doi.org/10.1093/nar/gkaf1175
  8. Pósfai, B., Jenei, A., Forika, G., Fintha, A., Sápi, Z., Somorácz, Á., Dénes, B., Salamon, F., Eizler, K.V., Giba, N., Semjén, D., Illyés, I., Kovács, K.A., Munkácsy, G., Papp, J., Sánta, F., Butz, H., Kuthi, L., 2026. Hemangioblastoma of the Kidney-A Comprehensive Clinical, Pathological, and Genetic Analysis of Four Cases. APMIS Acta Pathol. Microbiol. Immunol. Scand. 134, e70147. https://doi.org/10.1111/apm.70147
  9. Szepesi-Nagy, I., Borosta, R., Szabo, Z., Tusnady, G.E., Pongor, L.S., Rona, G., 2026. Frag’n’Flow: automated workflow for large-scale quantitative proteomics in high performance computing environments. BMC Bioinformatics 27, 18. https://doi.org/10.1186/s12859-025-06305-y
  10. Ungvari, Z., Fekete, J.T., Fekete, M., Lehoczki, A., Gulej, R., Sorond, F., Liotta, E., Prodan, C.I., Toth, P., Kiss, C., Ungvari, A., Győrffy, B., 2026a. Mortality, functional outcome, and bleeding risk after early versus delayed thrombectomy. GeroScience 48, 2029–2042. https://doi.org/10.1007/s11357-025-01915-z
  11. Ungvari, Z., Fekete, M., Buda, A., Lehoczki, A., Fekete, J.T., Munkácsy, G., Varga, P., Ungvari, A., Győrffy, B., 2026b. No detectable impact of short-term treatment delays on lung cancer survival. GeroScience 48, 793–805. https://doi.org/10.1007/s11357-025-01684-9
  12. Ungvari, Z., Fekete, M., Buda, A., Lehoczki, A., Fekete, J.T., Varga, P., Ungvari, A., Győrffy, B., 2026c. Depression increases cancer mortality by 23-83%: a meta-analysis of 65 studies across five major cancer types. GeroScience 48, 293–309. https://doi.org/10.1007/s11357-025-01676-9
  13. Ungvari, Z., Fekete, M., Buda, A., Lehoczki, A., Munkácsy, G., Scaffidi, P., Bonaldi, T., Fekete, J.T., Bianchini, G., Varga, P., Ungvari, A., Győrffy, B., 2026d. Quantifying the impact of treatment delays on breast cancer survival outcomes: a comprehensive meta-analysis. GeroScience 48, 1173–1187. https://doi.org/10.1007/s11357-025-01719-1
  14. Ungvari, Z., Menyhart, O., Lehoczki, A., Fekete, M., Bianchini, G., Győrffy, B., 2026e. PCSK9 expression and cancer survival: a prognostic biomarker at the intersection of oncology and geroscience. GeroScience 48, 435–449. https://doi.org/10.1007/s11357-025-01733-3
  15. Ungvari, Z., Menyhart, O., Lehoczki, A., Fekete, M., Fazekas-Pongor, V., Ocana, A., Varga, P., Győrffy, B., 2026f. NRF2 pathway activation predicts poor prognosis in lung cancer: a cautionary note on antioxidant interventions. GeroScience 48, 1345–1356. https://doi.org/10.1007/s11357-025-01736-0
  16. Ungvári, Z., Menyhart, O., Ocana, A., Fekete, M., Lehoczki, A., Győrffy, B., Senescence-associated gene signatures predict survival in lung cancer: a multi-cohort analysis. GeroScience 48, 577–590. https://doi.org/10.1007/s11357-025-01894-1
  17. Ungvari, Z., Menyhárt, O., Ocana, A., Lehoczki, A., Fekete, M., Bianchini, G., Győrffy, B., Subtype-specific sirtuin expression signatures link mitochondrial-epigenetic networks to breast cancer survival. GeroScience. https://doi.org/10.1007/s11357-026-02143-9

Utolsó frissítés: 2026.04.08.